Yes it's all gone a bit quiet.
This is taken from the presentation showing what announcements are due:
In terms of market cap / share price things should move a little once the first patient is treated. Until that time the price will stay as it is imo. Timeline? not sure when that will be, hopefully soon.
The NASDAQ-listed company Chemocentryx is probably the closest comparison to SBN however they are ahead in terms of trials.
Yes it's all gone a bit quiet. This is taken from the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
